AlphaFold predicted structure
PTPN1 · P18031

Mean pLDDT
81.3/ 100
Confident
435 residues
Confidence breakdown
- Very high(≥ 90)67%
- Confident(70–90)8%
- Low(50–70)2%
- Very low(< 50)23%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
protein tyrosine phosphatase non-receptor type 1
Annotations refreshed 1 month ago.
Moderate Evidence (Amber)
Autoinflammatory disorders
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedChildhood onset dystonia, chorea or related movement disorder
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedChildhood onset hereditary spastic paraplegia
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedWhite matter disorders and cerebral calcification - narrow panel
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedneurodegenerative disease
Alzheimer disease
Parkinson disease
multiple sclerosis
lysosomal storage disease
hypothyroidism
mathematical ability
colorectal cancer
tooth disorder
type 1 diabetes mellitus
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Tyrosine-protein phosphatase non-receptor type 1
Tyrosine-protein phosphatase which acts as a regulator of endoplasmic reticulum unfolded protein response. Mediates dephosphorylation of EIF2AK3/PERK; inactivating the protein kinase activity of EIF2AK3/PERK. May play an important role in CKII- and p60c-src-induced signal transduction cascades. May regulate the EFNA5-EPHA3 signaling pathway which modulates cell reorganization and cell-cell repulsion. May also regulate the hepatocyte growth factor receptor signaling pathway through dephosphorylation of MET
Curated MONDO disease pages that list PTPN1 among their top associated genes.
PTPN1 · P18031

Mean pLDDT
81.3/ 100
Confident
435 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0